MILTOWN Drug Patent Profile
When do Miltown patents expire, and what generic alternatives are available?
Miltown is a drug marketed by Medpointe Pharm Hlc and is included in two NDAs.
The generic ingredient in MILTOWN is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Miltown
A generic version of MILTOWN was approved as meprobamate by INVAGEN PHARMS on February 27th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MILTOWN?
- What are the global sales for MILTOWN?
- What is Average Wholesale Price for MILTOWN?
Summary for MILTOWN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4,515 |
| DailyMed Link: | MILTOWN at DailyMed |
US Patents and Regulatory Information for MILTOWN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medpointe Pharm Hlc | MILTOWN | meprobamate | TABLET;ORAL | 009698-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Medpointe Pharm Hlc | MILTOWN | meprobamate | TABLET;ORAL | 009698-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Medpointe Pharm Hlc | MILTOWN | meprobamate | TABLET;ORAL | 083919-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
